<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>104(6)</volume><submitter>Patnaik MM</submitter><funding>NCATS NIH HHS</funding><journal>Haematologica</journal><pagination>e236-e239</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6545828</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Clinical correlates, prognostic impact and survival outcomes in chronic myelomonocytic leukemia patients with the &lt;i>JAK2&lt;/i>V617F mutation.</pubmed_title><pmcid>PMC6545828</pmcid><funding_grant_id>KL2 TR000136</funding_grant_id><funding_grant_id>KL2 TR002379</funding_grant_id><pubmed_authors>Finke CM</pubmed_authors><pubmed_authors>Ketterling RP</pubmed_authors><pubmed_authors>Tefferi A</pubmed_authors><pubmed_authors>Pophali PA</pubmed_authors><pubmed_authors>Horna P</pubmed_authors><pubmed_authors>Gangat N</pubmed_authors><pubmed_authors>Pardanani A</pubmed_authors><pubmed_authors>Lasho TL</pubmed_authors><pubmed_authors>Patnaik MM</pubmed_authors><pubmed_authors>Mangaonkar AA</pubmed_authors></additional><is_claimable>false</is_claimable><name>Clinical correlates, prognostic impact and survival outcomes in chronic myelomonocytic leukemia patients with the &lt;i>JAK2&lt;/i>V617F mutation.</name><description/><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Jun</publication><modification>2025-04-04T19:55:57.576Z</modification><creation>2025-04-04T19:55:57.576Z</creation></dates><accession>S-EPMC6545828</accession><cross_references><pubmed>30606787</pubmed><doi>10.3324/haematol.2018.208082</doi></cross_references></HashMap>